Stem cell agency lists own board members with conflicts of interest
By David Jensen,
Capitol Weekly
| 08. 24. 2022
In a first in its 18-year history, the California stem cell agency has begun posting on its website a list of its governing board members who have conflicts of interest as they award hundreds of millions of dollars.
The most recent example comes next Tuesday in a $48 million round that will benefit at least 16 public and private colleges in the Golden State and up to 400 students at a cost of $58,220 each.
The latest list shows that 25 members of CIRM’s 35-member governing board have conflicts in the round to be considered Tuesday.
The public conflict postings reflect an awareness of the need for transparency at the $12 billion agency, officially known as the California Institute for Regenerative Medicine (CIRM). The research effort was created by voters in 2004 via a ballot initiative, Proposition 71. The measure gave many of the potential beneficiaries a seat at the table where the money is handed out.
Since CIRM’s inception, about 80 percent of its awards — now totaling $3 billion — have gone to institutions that have...
Related Articles
By Ian Sample, The Guardian | 03.08.2024
Scientists are a step closer to making IVF eggs from patients’ skin cells after adapting the procedure that created Dolly the sheep, the first cloned mammal, more than two decades ago.
The work raises the prospect of older women being...
By Ramon Antonio Vargas, The Guardian | 02.28.2024
Doctors say a man in California who contracted blood cancer while living with HIV is in remission from both potentially fatal illnesses thanks to a treatment they are hailing as remarkable and encouraging.
Paul Edmonds is only the fifth-known person...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
By Adam Zewe, MIT News | 02.07.2024
A tiny device built by scientists at MIT and the Singapore-MIT Alliance for Research and Technology could be used to improve the safety and effectiveness of cell therapy treatments for patients suffering from spinal cord injuries.
In cell therapy, clinicians...